Anil Ambani, Others Appeal Against SEBI's Rs 625 Crore Penalty Directive
Anil Ambani and other entities have filed an appeal against the Securities and Exchange Board of India's order imposing a fine of over Rs 625 crore. The Securities Appellate Tribunal will hear the appeal and related matters on Oct. 18.
SEBI had barred Ambani and the other implicated entities from participating in the securities market for five years due to allegations of fund diversion from Reliance Home Finance Ltd. (RHFL). While Ambani faces a five-year restriction, RHFL itself has been sanctioned for only six months.
The market regulator's extensive investigation found that Ambani, aided by key managerial personnel at RHFL, allegedly orchestrated a fraudulent scheme to syphon funds by presenting them as loans to connected entities.
SEBI's 222-page report put forth serious concerns about RHFL's lending practices, noting that the board had expressed apprehensions about the composition of its lending portfolio, which were ultimately disregarded.
The report revealed that loans worth hundreds of crores were approved for companies with little to no financial backing, leading to widespread defaults. RHFL's loan portfolio skyrocketed from Rs 3,742.60 crore in 2017-18 to Rs 8,670.80 crore in 2018-19, exacerbating the company's own debt obligations.
Additionally, the investigation uncovered significant procedural flaws in loan applications, including incomplete documentation and inadequate eligibility checks. Despite these red flags, RHFL's credit committees continued to approve loans, raising further questions about governance within the organisation.
Other individuals involved in the case, such as Amit Bapna, Ravindra Sudhalkar, and Pinkesh R. Shah, face hefty fines ranging from Rs 21 crore to Rs 27 crore. Several other entities implicated in the scheme, including Adhar Project Management and Consultancy Pvt. and Reliance Big Entertainment Pvt., have also been fined Rs 25 crore each.
SEBI's findings were prompted by multiple complaints regarding fund diversion at RHFL, revealing a troubling pattern of expedited loan approvals.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.
-
It's Time To Take The GST Council's Bet On Trust Global
Payment records can prove India's services exports, and clear, proportionate rules can bring foreign digital sellers into the tax net.
-
Opinion | India at 38: From Innovation Overperformer to Innovation Powerhouse
India now has 453 VC-backed deep science startups, 18 of them late-stage, after 117 percent growth since 2020. Laurus Labs, at USD 9.3 billion, is the most valuable deep science company in any middle-income economy outside China.